Caplin Point Laboratories Profit & Loss Annual

BSE: 524742 | NSE: CAPLIPOINT | ISIN: INE475E01026 | Sector: Biotechnology & Drugs

2,513.80 +38.60 (1.56%)Updated : 13 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	1,499.11	1,352.55	1,195.18	1,069.96
Other Net	115.54	6.81	5.18	5.12
Diluted Weighted Average Shares	7.62	7.63	7.63	7.65
Depreciation/ Amortization	72.77	65.96	53.44	44.99
Operating Income	688.08	584.92	498.92	396.77
Net Income	641.24	536.31	457.09	376.26
Income Availableto Com Excl Extra Ord	641.24	536.31	457.09	376.26
Other Operating Expenses Total	361.51	-	-	-
Net Income Before Taxes	802.79	676.78	564.43	451.35
Minority Interest	-8.49	-4.78	-4.33	-0.73
Net Income After Taxes	649.73	541.09	461.42	376.99
Income Availableto Com Incl Extra Ord	641.24	536.31	457.09	376.26
Costof Revenue Total	865.68	815.80	762.91	694.80
Gross Profit	1,321.51	1,121.67	931.19	771.93
Interest Inc( Exp) Net- Non- Op Total	-0.83	88.81	60.98	49.82
Diluted Net Income	641.24	536.31	457.09	376.26
DPS- Common Stock Primary Issue	8.00	6.00	5.00	4.50
Provisionfor Income Taxes	153.06	135.69	103.01	74.36
period Type	-	-	-	-
Net Income Before Extra Items	641.24	536.31	457.09	376.26
Total Revenue	2,187.19	1,937.47	1,694.10	1,466.73
period Length	12.00	12.00	12.00	12.00
Revenue	2,187.19	1,937.47	1,694.10	1,466.73
Selling/ General/ Admin Expenses Total	199.15	394.11	305.11	266.98
Diluted Normalized EPS	84.11	70.64	59.97	49.22
Diluted EPS Excluding Extra Ord Items	84.11	70.25	59.90	49.18
Gain( Loss)on Saleof Assets	-	-3.76	-0.65	-0.36
Unusual Expense( Income)	-	0.00	-	-
Research Development	-	76.68	73.72	63.19

*All figures in crores except per share values

Trending Stocks

5,098.20+155.20(3.14%)

1,102.85+20.85(1.93%)

2,024.95+23.05(1.15%)

1,072.00-24.05 (-2.19%)

310.50-4.95 (-1.57%)

Related News